Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemia

Key Points

• Menin-MLL inhibitors show promising efficacy in acute myeloid leukemia treatment, particularly targeting specific molecular pathways.
• Preliminary results indicate a significant reduction in tumor growth rates with optimized dosing of inhibitors in cell line models.
• Assessment using molecular modeling strategies and biochemical assays identifies key interactions between menin and MLL proteins.
• These findings highlight the potential for developing targeted therapies in acute myeloid leukemia, requiring further validation in clinical settings.